References
- Andre-Obadia N, Mertens P, Gueguen A, et al. Pain relief by rTMS: differential effect of current flow but no specific action on pain subtypes. Neurology 2008;71:833-40
- Andre-Obadia N, Magnin M, Garcia-Larrea L. On the importance of placebo timing in rTMS studies for pain relief. Pain 2011;152:1233-7
- Goffaux P, Leonard G, Marchand S, et al. Placebo analgesia. In: Beaulieu P, Lussier D, Porreca F, Dickenson AH, eds. Pharmacology of Pain. Seattle: IASP Press, 2010: pp. 451-73
- Benedetti F, Pollo A, Lopiano L, et al. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J Neurosci 2003;23:4315-23
- Berthelot JM, Le Goff B, Maugars Y. The hawthorne effect: stronger than the placebo effect?. Joint Bone Spine 2011;78:335-6
- Braunholtz DA, Edwards SJ, Lilford RJ. Are randomized clinical trials good for us (in the short term)? evidence for a "trial effect". J Clin Epidemiol 2001;54:217-24
- Colloca L, Benedetti F. Placebos and painkillers: is mind as real as matter?. Nat Rev Neurosci 2005;6:545-52
- Leonard G, Goffaux P, Marchand S. Deciphering the role of endogenous opioids in high-frequency TENS using low and high doses of naloxone. Pain 2010;151:215-19
- Putt ME, Ravina B. Randomized, placebo-controlled, parallel group versus crossover study designs for the study of dementia in Parkinson’s disease. Control Clin Trials 2002;23:111-26
- Senn S. Cross-over Trials in Clinical Research. New York: John Wiley & Sons, 2002
- Fedele L, Marchini M, Acaia B, et al. Dynamics and significance of placebo response in primary dysmenorrhea. Pain 1989;36:43-7
- Chizh BA, Priestley T, Rowbotham M, et al. Predicting therapeutic efficacy - experimental pain in human subjects. Brain Res Rev 2009;60:243-54
- Colloca L, Lopiano L, Lanotte M, et al. Overt versus covert treatment for pain, anxiety, and Parkinson’s disease. Lancet Neurol 2004;3:679-84